Pier Federico Gherardini

机构：University of Rome Tor Vergata · ORCID：0000-0002-9030-2154

发表论文 84 篇 · 总被引 4961 次 · h-index 29

代表论文

• Systemic Immunity Is Required for Effective Cancer Immunotherapy (2017 · Cell · 被引 996)
• Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial (2022 · Nature Medicine · 被引 381)
• Highly multiplexed simultaneous detection of RNAs and proteins in single cells (2016 · Nature Methods · 被引 344)
• High response rate to PD-1 blockade in desmoplastic melanomas (2018 · Nature · 被引 340)
• Epigenomic-Guided Mass Cytometry Profiling Reveals Disease-Specific Features of Exhausted CD8 T Cells (2018 · Immunity · 被引 332)
• CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b study (2020 · The Lancet Oncology · 被引 311)